Staying afloat, page-31

First 31 Last

Share
Profile

Follow
sewell64

5,335 Posts.

309

02/03/25

09:06

Post #: 78095991
Share

Originally posted by Gsinc: ↑

Speculative micro and small cap stocks go hand in hand with dilution. I don’t necessarily disagree that a new CEO may make a difference but I also the think the company is on the right track.

Now the paradox with this this is that the SP hasn’t given many holders confidence that they should stick with it.

Unfortunately many similar companies go through the same process. Over promise, under deliver, burn cash and miss timelines. It’s Frustrating but that’s the speculative stock game. If we want more certainty and better stable management then established companies are the way to go. The funny thing is though though is that many of those established companies were once in 4DX position making the same mistakes.

Again not saying serious questions shouldn’t be asked of AF, especially when it comes to timelines etc but not 100% sure pushing out the founder and putting in an outsider would
change anything

Expand

A brief look at the Promedicus history shows a similar depressed SP for years before taking off. Have patience.

4DX Price at posting: 38.5¢ Sentiment: Hold Disclosure: Held
7 Upvote

0 Great analysis

Reply

Top Stories

PAR

Paradigm Biopharmaceuticals makes key acquisition moving into FY26

OCC

Orthocell sees 4% jump as Remplir used in first US surgery. But is that low?

NATO’s 5% target: Why Almonty Industries’ mega mine and NASDAQ listing are a perfect fit for investors

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

BPH

Australia’s gas crisis is here – and dying coal plants aren’t helping

First 31 Last

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last 24.0¢		Change -0.010(4.00%)		Mkt cap ! $114.0M

Open	High	Low	Value	Volume
25.5¢	25.5¢	24.0¢	$438.5K	1.795M

Buyers (Bids)

No.	Vol.	Price($)
13	114830	23.5¢

Sellers (Offers)

Price($)	Vol.	No.
24.0¢	84416	5

View Market Depth

No.	Vol.	Price($)
13	114830	0.235
12	75050	0.230
10	280070	0.225
4	173799	0.220
3	35750	0.215

Price($)	Vol.	No.
0.240	84416	5
0.245	277307	4
0.250	115755	4
0.255	113349	5
0.260	314410	4

Last trade - 12.51pm 27/06/2025 (20 minute delay)

4DX (ASX) Chart

Staying afloat, page-31

Paradigm Biopharmaceuticals makes key acquisition moving into FY26

Orthocell sees 4% jump as Remplir used in first US surgery. But is that low?

NATO’s 5% target: Why Almonty Industries’ mega mine and NASDAQ listing are a perfect fit for investors

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

Australia’s gas crisis is here – and dying coal plants aren’t helping

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Staying afloat, page-31

Top Stories

Paradigm Biopharmaceuticals makes key acquisition moving into FY26

Orthocell sees 4% jump as Remplir used in first US surgery. But is that low?

NATO’s 5% target: Why Almonty Industries’ mega mine and NASDAQ listing are a perfect fit for investors

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

Australia’s gas crisis is here – and dying coal plants aren’t helping

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News